Pfizer's (PFE) short interest as a percent of float has fallen 9.0% since its last report. According to exchange reported data, there are now 103.47 million shares sold short, which is 1.82% of all ...

The global market for sodium-glucose cotransporter-2 (SGLT2) inhibitors is set to expand rapidly, fueled by rising demand ...

A few years ago, Pfizer (NYSE: PFE) saw revenue soar to record heights thanks to coronavirus-related sales, from its vaccine ...

Remember when Pfizer was everywhere? From nightly news to every vaccine card in your wallet, it was the face of the pandemic response. But with COVID now in the rearview mirror, the spotlight has ...